COVID-19: An Indian perspective.

Lockdown, quarantine, self-isolation, personal protection equipment, and social distancing have become words of daily usage ever since the world health organization declared coronavirus disease 2019 (COVID-19) as a pandemic. The impact of COVID-19 extends over the medical field, economy, education, and politics. Though the knowledge of the virus is evolving, we are yet to find a solution. India, country with the second largest population, went into a phase of lockdown from 25th March 2020 to 31st May 2020. There was phased measure to "Unlock" starting from 1st June 2020. This has affected the clinical practice and training of the resident. The challenges faced during this unprecedented time are multifaceted which includes overcrowding, healthcare system, and educational background. Indian Association of Cardiovascular-Thoracic Surgeons kept continuing the educational program through a series of "Masterclass."

An Indian study: impact of COVID-19 on clinical decision-making and consensus in cardiac surgery practice across the country.

PURPOSE: There is a paucity of evidence and guidelines to support clinical decisions in the present unprecedented time. We aimed to use the experience and consensus of the cardiac surgeons for clinical decisions until evidence-based guidelines are formed. METHODS: An electronic questionnaire was emailed to all the 1434 members of the Indian Association of Cardiovascular and Thoracic Surgery, starting from May 13, 2020, and the members were followed up with reminder emails. For a wider reach, social media like WhatsApp was also used to circulate the questionnaire. Participation was voluntary and anonymized. An effective consensus was considered when > 70% opted the same opinion, and moderate consensus when > 50% opted the same opinion. RESULTS: A total of 174 responses were obtained from the surgeons across the country. An effective consensus was obtained for the following: (i) emergency surgery in acute type A aortic dissection, (ii) urgent surgery in significant left main stem disease and mitral/aortic valves with pulmonary oedema, (iii) elective surgery in stable triple vessel disease and (iv) preoperative nasal swab examination for all patients undergoing surgery. CONCLUSION: In the present era, where evidence is evolving and the country is entering a phase after lockdown, the surgeons face a dilemma in operating patients. These consensuses provide interim recommendation; still further evidence is published.

IACTS guidelines: practice of cardiovascular and thoracic surgery in the COVID-19 era.

Patients undergoing cardiovascular and thoracic procedures are at an accentuated risk of higher morbidity and mortality, which are a consequence of the proliferative nature of the severe acute respiratory syndrome-corona virus 2 (SARS-CoV-2) on the lung vasculature, which in turn reflects as a cascading effect on the interdependent physiology of the cardiovascular and pulmonary organ systems. These are secondary to systemic inflammatory response syndrome and immunosuppressive responses to surgery and mechanical ventilation. Thus, the need to establish guidelines for the practice of cardiothoracic surgery which is safe for both the patient and the healthcare team presents as a priority, which is the mainstay of this article.